Clinical Reasoning: A Young Woman With Rapidly Progressive Weakness and Paresthesia
Citation Manager Formats
Make Comment
See Comments

Abstract
A 24-year-old Middle Eastern woman presented with a 2-month history of rapidly progressive asymmetric weakness and paresthesia that began in her left lower extremity and progressed to involve both legs and arms. It was associated with overflow urinary incontinence and significant weight loss. In addition, she complained of a constant occipital headache that worsened in the supine position and was associated with photophobia, tinnitus, nausea, vomiting, and horizontal binocular diplopia. She also had signs of meningismus, decreased left facial sensation, and right sensorineural hearing loss. Because multifocal localization suggests a wide variety of possible differential diagnoses, this study expands on the differential of a subacute multifocal process while highlighting the importance of identifying appropriate risk factors and performing a relevant yet focused diagnostic workup.
Section 1
A 24-year-old Middle Eastern woman presented with a 2-month history of generalized weakness prominent in the left lower extremity. Her symptoms began with proximal left leg heaviness, progressing to both legs. Weakness was associated with gradually worsening paresthesia and reduced sensation in the left lower limb, originating from the hip down to the foot. She also had lip and bilateral numbness in the distal upper limbs and complained of a gradual-onset constant occipital headache with pain radiating to the neck, worsening in the supine position, and not relieved by oral analgesics. Headache was associated with photophobia, tinnitus, nausea, vomiting, and horizontal binocular diplopia, which was exacerbated when looking at far objects. The patient also experienced overflow urinary incontinence. She reported a significant weight loss of 13 kg but had no fever or night sweats.
Her medical history was significant only for brucellosis, diagnosed 2 years ago with persistent high-grade fever, chills, sweating, and diffuse myalgia after ingestion of unpasteurized milk. Family and social histories were unremarkable.
On examination, the patient was afebrile with normal blood pressure. The patient showed positive meningismus signs, including nuchal rigidity, Kernig sign, and jolt accentuation. Mental status and cognition remained intact. Cranial nerve examination revealed horizontal binocular diplopia with partially limited abduction of both eyes, impaired left facial sensation to pinprick and temperature, and right sensorineural hearing loss. The other cranial nerves were intact with normal fundi.
Motor examination revealed diffuse muscle wasting and decreased tone in the upper and lower extremities with no observable fasciculations. Her strength was 4/5 throughout the study period, except for the left lower extremity, which demonstrated foot drop and no antigravity strength. Reflexes were absent in the left biceps, brachioradialis, knee, and ankle. Hyporeflexia was observed on the right side. Plantar responses were flexor responses, and the Hoffman test result was negative.
Sensory examination revealed reduced sensation of light touch, temperature, and pinprick over the first 2 fingers and lateral forearm of the left upper limb along with the entire left lower limb. Vibration sensation was decreased in the left lower limb up to the knee level. The sensation of joint position in the toes was intact bilaterally. Systemic examination results were unremarkable, with no hepatosplenomegaly.
Questions for Consideration:
What is the localization of this clinical presentation?
What are the possible differential diagnoses?
Section 2
The patient's symptoms were consistent with multifocal localization, including a lower motor neuron pattern and marked, asymmetric, generalized weakness in the left lower limb with left-sided areflexia, decreased tone, atrophy accompanied by sensory changes in the same limb, and overflow incontinence suggesting peripheral nervous system pathology, which potentially localized to the lumbar roots. Numbness of both arms and fingers, with dermatomal sensory loss, hyporeflexia, and a pattern of generalized weakness, indicated cervical polyradiculopathy. Perioral numbness with decreased left facial sensation suggested a lesion in the left trigeminal nerve involving the ophthalmic, maxillary, and mandibular branches, while hearing loss in the right ear suggested a lesion in the right vestibulocochlear nerve. Finally, occipital headache worsening in the supine position accompanied by photophobia, tinnitus, nausea, vomiting, and horizontal diplopia indicated increased intracranial pressure.
Polyradiculopathies along with cranial neuropathies suggested a multifocal leptomeningeal disease process, as these findings collectively localized to the brain and spinal cord meninges. Differential diagnoses of a subacute leptomeningeal process included bacterial and fungal infections, particularly tuberculosis and cryptococcosis, along with infections associated with raw milk ingestion and endemic infectious diseases of the Middle East such as brucellosis and listeriosis; neoplastic conditions such as leptomeningeal carcinomatosis and lymphoma; and rare inflammatory conditions such as sarcoidosis, IgG4, and histiocytosis.
Questions for Consideration:
What investigations would you perform?
What is the final diagnosis?
What is the treatment for this patient?
Section 3
Laboratory tests revealed a normal leukocyte count of 4.8 × 109/L (4.5–11.0 × 109/L) with relative lymphocytosis of 67% (20%–45%). Metabolic panel results were within the normal range, with unremarkable C-reactive protein levels and erythrocyte sedimentation rate.
Blood and acid-fast bacillus cultures and serologic tests for Mycobacterium sp., various fungi, and Brucella sp. showed negative results. However, the serum agglutination test revealed high blood anti-Brucella antibody titer of 1:320.
The CSF opening pressure was high at 370 mmH2O. The fluid was yellow and turbid. The protein level was markedly high at 138 mg/dL (15–45 mg/dL), whereas the glucose concentration, 24.84 mg/dL (40–69.3 mg/dL), was markedly lower than that in the serum. The erythrocyte count was unremarkable. Leukocyte count (80 leukocytes/μL) revealed lymphocytic pleocytosis (90% lymphocytes and 10% polymorphonuclear leukocytes). CSF cultures were negative for bacteria, fungi, and mycobacteria. The anti-Brucella antibody titer in the CSF was elevated to 1:80.
Brain MRI with contrast demonstrated multiple patchy subcortical, periventricular, and juxtacortical fluid-attenuated inversion recovery white matter hyperintensities with no postcontrast enhancement. It also demonstrated diffuse cranial nerve enhancement involving the bilateral oculomotor, trigeminal, abducens, and right vestibulocochlear nerves (Figure, A–C). Spinal cord MRI showed cauda equina nerve root enhancement (Figure, D).
(A) Axial fluid-attenuated inversion recovery MRI demonstrating multiple bilateral subcortical and periventricular white matter lesions. (B, C) Axial T1-weighted gadolinium-enhanced MRI showing smooth enhancement in the left abducens (yellow arrow) (B), right vestibulocochlear (blue arrow) (B), and left trigeminal nerves (C). (D) Sagittal T1-weighted gadolinium-enhanced MRI of the lumbar spine showing cauda equina nerve root enhancement.
Nerve conduction studies and needle electromyography showed normal sensory nerve action potentials and normal-to-low-normal compound muscle action potentials, with evidence of subacute-to-chronic cervical and lumbar radiculopathies. In view of the endemic regional origin, neurologic and constitutional manifestations, history of brucellosis and unpasteurized milk consumption, and CSF lymphocytosis with increased protein and decreased glucose levels, combined with high levels of anti-Brucella antibody titer, neurobrucellosis was the final diagnosis.
On further reviewing the patient’s brucellosis history from 2 years ago, she reported stopping her antibiotics independently after 1 month of treatment because of pregnancy and improvement in symptoms.
The patient was treated with a 1-month course of 2 g of intravenous ceftriaxone twice daily and a 4-month course of 600 mg of oral rifampicin and 100 mg of oral doxycycline. Her headache markedly improved, and diplopia resolved within a few days after her admission. The patient regained control of urination. However, she continued to experience abnormal sensations and generalized weakness, requiring her to rely on a wheelchair.
The patient's condition improved after completing the antibiotic therapy. At follow-up 8 months after treatment initiation, she could walk and function independently. She had minor residual deficits on examination, including mild lower limb weakness and right sensorineural hearing loss.
Discussion
Brucellosis is the most common zoonotic infection worldwide. It is caused by Brucella species, which are gram-negative, aerobic, facultative intracellular coccobacilli that spread through contact with infected sheep, goats, cattle, and other animals. Brucellosis is frequently acquired through ingestion of unpasteurized milk or milk products,1 and its incidence is highest in countries with suboptimal public and domestic animal health care programs. Endemic areas include countries in the Mediterranean basin, Middle East, Asia, Africa, Eastern Europe, the Caribbean, Mexico, and Central and South America.2
Brucellosis can lead to various complications, prolonged treatment, and repeated relapses. The symptoms of Brucella infection typically present within 2 months of bacterial exposure. With a wide range of clinical manifestations, patients may present with nonspecific symptoms such as fever, weight loss, and arthralgia. Hepatomegaly and splenomegaly are the most common physical findings.1,3
Neurologic complications occur in 10% of cases.1 Most patients with neurobrucellosis characteristically experience severe and constant headaches. Other common neurologic symptoms include blurred vision, behavioral changes, agitation, muscle weakness, and neck rigidity. Cranial neuropathies are common and mostly affect the abducens, face, and vestibulocochlear nerves, resulting in facial paralysis and sensorineural hearing loss. Lumbosacral radiculopathy and elevated intracranial pressure have also been reported.3,4
Imaging findings are variable and may include inflammatory changes marked by granulomas; nodular lesions; abnormal enhancement of the cranial nerves, meninges, perivascular spaces, or lumbar nerve roots; white matter changes with diffuse, periventricular, or focal demyelinating appearance; and vascular insults such as lacunar infarcts, small hemorrhages, or venous thrombosis.3,5 Therefore, this disease should be considered in the differential diagnosis of other conditions, particularly multiple sclerosis. By contrast, neurobrucellosis white matter lesions have not been reported to show postcontrast enhancement and rarely involve the corpus callosum.5
In patients with laboratory-confirmed brucellosis based on either positive blood cultures or a serum agglutination test with a titer of ≥1:160, the following 4 criteria were proposed to diagnose neurobrucellosis: (1) symptoms and signs suggestive of the disease; (2) detection of Brucella spp. and anti-Brucella antibody titer in the CSF; (3) lymphocytosis with increased protein and decreased glucose levels in the CSF, and (4) the presence of suspicious imaging abnormalities.4
There is no consensus on an appropriate approach for neurobrucellosis treatment. Combining rifampicin, doxycycline, and either trimethoprim-sulfamethoxazole or ceftriaxone for 3–12 months, depending on the CSF response, has been recommended. Prednisolone is recommended to prevent long-term neurobrucellosis complications such as iritis, papilledema, myelopathy, polyneuropathy, or cranial nerve palsies.3 One-fifth of the patients treated for neurobrucellosis experience long-term sequelae, most commonly persistent hearing loss and lower limb weakness.1,3 An additional paragraph discussing brucellosis relapse has been provided in eAppendix 1 (links.lww.com/WNL/D20).
In summary, neurobrucellosis should be considered in the differential diagnosis of a subacute leptomeningeal process with constitutional findings when evaluating immigrant patients from endemic regions. This treatable condition should be suspected to ensure the early initiation of treatment and prevention of long-term sequelae.
Ethical Considerations
The study participant provided written informed consent to disclose. This study was exempt from the need to obtain approval from an ethics board due to the study type.
Study Funding
No targeted funding reported.
Disclosure
The authors report no disclosures relevant to the manuscript. Go to Neurology.org/N for full disclosures.
Acknowledgment
The authors thank Editage (editage.com) and Scribbr (scribbr.com) for English language editing.
Appendix Authors

Footnotes
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
Submitted and externally peer reviewed. The handling editor was Resident and Fellow Deputy Editor Katherine Fu, MD.
- Received December 14, 2022.
- Accepted in final form June 2, 2023.
- © 2023 American Academy of Neurology
References
- 1.↵
- Bennett J,
- Dolin R
- Gul H,
- Erdem H
- 2.↵Areas at Risk. Centers for Disease Control and Prevention. Updated November 12, 2012. Accessed September 14, 2022. cdc.gov/brucellosis/exposure/areas.html.
- 3.↵
- 4.↵
- 5.↵
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Related Articles
- No related articles found.